ACCC co-signed a letter in strong support of the passage of the Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act (H.R. 5030/S. 2706) to ensure more patients—regardless of their race, ethnicity, economic means, or geographic location—have a chance to enroll in clinical trials.